Showing results (381-390 of 1,340) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|April 20, 2022
Filamin A increases aggressiveness of human neuroblastomaSashidar Bandaru, Bharat Prajapati, Prasanna Kumar Juvvuna, et al.
Neuro-Oncology Advances|February 24, 2022
Predictive accuracy of T2-FLAIR mismatch sign for the IDH-mutant, 1p/19q noncodeleted low-grade glioma: An updated systematic review and meta-analysisYoon Ah Do, Se Jin Cho, Byung Se Choi, et al.
Neuro-Oncology Advances|February 14, 2022
Integrating morphologic and molecular histopathological features through whole slide image registration and deep learningKevin Faust, Michael K Lee, Anglin Dent, et al.
Neuro-Oncology Advances|November 3, 2021
Pharmacoresistant seizures and IDH mutation in low-grade gliomasCarlos Eduardo Correia, Yoshie Umemura, Jessica R Flynn, et al.
Neuro-Oncology Advances|November 3, 2021
Intraoperative DNA methylation classification of brain tumors impacts neurosurgical strategyLuna Djirackor, Skarphedinn Halldorsson, Pitt Niehusmann, et al.
Neuro-Oncology Advances|March 11, 2022
XAF1 directs glioma response to temozolomide through apoptotic transition of autophagy by activation of ATM-AMPK signalingMin-Goo Lee, Zisun Choi, Na-Jung Lim, et al.
Neuro-Oncology Advances|March 18, 2022
A systematic review of amino acid PET in assessing treatment response to temozolomide in gliomaKiana Y Prather, Christen M O'Neal, Alison M Westrup, et al.
Neuro-Oncology Advances|March 18, 2022
Noninvasive differentiation of molecular subtypes of adult nonenhancing glioma using MRI perfusion and diffusion parametersIlanah J Pruis, Stephan R Koene, Sebastian R van der Voort, et al.
Neuro-Oncology Advances|March 23, 2022
Clinical validation of a spectroscopic liquid biopsy for earlier detection of brain cancerJames M Cameron, Paul M Brennan, Georgios Antoniou, et al.
Neuro-Oncology Advances|April 11, 2022
Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignanciesYazmin Odia, Ludimila Cavalcante, Howard Safran, et al.
Pageof 134